Cancer Research Annual Meeting 2010  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 67, 4774, May 15, 2007. doi: 10.1158/0008-5472.CAN-06-4315
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Samara, R. N.
Right arrow Articles by Jessup, J. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Samara, R. N.
Right arrow Articles by Jessup, J. M.

Cell, Tumor, and Stem Cell Biology

Carcinoembryonic Antigen Inhibits Anoikis in Colorectal Carcinoma Cells by Interfering with Trail-R2 (DR5) Signaling

Raed N. Samara1, Luciana M. Laguinge1 and J. Milburn Jessup1,2

Departments of 1 Oncology and 2 Surgery, Georgetown University Medical Center, Washington, District of Columbia

Requests for reprints: John M. Jessup, Department of Oncology, Georgetown University Medical Center, Box 571467, Room LF-09, Preclinical Science Building, 3900 Reservoir Road, Northwest, Washington, DC 20057. Phone: 301-435-9010; Fax: 301-401-7819; E-mail: jessupj{at}mail.nih.gov.

Carcinoembryonic antigen (CEA) is a tumor marker that is associated with metastasis, poor response to chemotherapy of colorectal cancer (CRC), and anoikis, a form of apoptosis caused by cell detachment from matrix that is dependent on TRAIL-R2 (DR5) and caspase-8 activation in CRC. Although CEA is a homophilic binding protein that may provide survival signals through homotypical cell aggregation, we now report that CEA binds TRAIL-R2 (DR5) directly in two-hybrid assays to decrease anoikis through the extrinsic pathway. Deletion of the PELPK sequence (delPELPK) of CEA (delPELPK CEA) restores sensitivity to anoikis while it maintains its cell aggregation function. Wild-type (WT) CEA also increases experimental hepatic metastasis, whereas the delPELPK CEA does not. Thus, membrane CEA interacts with DR5 to inhibit anoikis and increase metastatic potential in CRC. [Cancer Res 2007;67(10):4774–82]




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
V. Kolla, L. W. Gonzales, N. A. Bailey, P. Wang, S. Angampalli, M. H. Godinez, M. Madesh, and P. L. Ballard
Carcinoembryonic cell adhesion molecule 6 in human lung: regulated expression of a multifunctional type II cell protein
Am J Physiol Lung Cell Mol Physiol, June 1, 2009; 296(6): L1019 - L1030.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
N. Shimony, I. Avrahami, R. Gorodetsky, G. Elkin, K. Tzukert, L. Zangi, L. Levdansky, L. Krasny, and Y. S. Haviv
A 3D rotary renal and mesenchymal stem cell culture model unveils cell death mechanisms induced by matrix deficiency and low shear stress
Nephrol. Dial. Transplant., June 1, 2008; 23(6): 2071 - 2080.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.